Description
QTY 4 1344461095 NEMOLIZUMAB CCP 30MG INJ
First action · last action
2024-09-19 · 2024-09-19
Transactions
1
First transaction's obligation
$12,253
Base + all options value (sum of deltas)
$12,253
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-09-19+$12,253= $12,253
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-09-19 | +$12,253 | $12,253 | QTY 4 1344461095 NEMOLIZUMAB CCP 30MG INJ |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI MNX4XY6QXEL3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0834 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $16,960 | FY2026 |
| 36C26226N0818 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $50,880 | FY2026 |
| 36C24526N0594 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $31,800 | FY2026 |
| 36C24526N0514 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $42,400 | FY2026 |
| 36C24526N0423 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $31,800 | FY2026 |
| 36C24526N0298 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $31,800 | FY2026 |
Other recipients under 6505 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25926F0310 | JANSSEN BIOTECH INC | NETWORK CONTRACT OFFICE 19 (36C259) | $384,719 | FY2026 |
| 36C25926N0409 | MEDI-PHYSICS, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $34,735 | FY2026 |
| 36C25926F0264 | JANSSEN BIOTECH INC | NETWORK CONTRACT OFFICE 19 (36C259) | $384,719 | FY2026 |
| 36C25926N0384 | SIRTEX MEDICAL INC | NETWORK CONTRACT OFFICE 19 (36C259) | $245,194 | FY2026 |
| 36C25926P0553 | COSETTE PHARMACEUTICALS, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $3,439 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25924P1512_3600_-NONE-_-NONE- · retrieved 2026-09-26.